Comparison Between Oral Melatonin and Hydroxyzine in Pediatric Patients Undergoing Adenotonsillectomy

NCT ID: NCT05680584

Last Updated: 2023-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE1

Total Enrollment

78 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-01

Study Completion Date

2024-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison between the effect of oral Melatonin and Hydroxyzine for Preventing Preoperative Anxiety in pediatric Patients Undergoing Adenotonsillectomy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to compare the effectiveness of preoperative oral melatonin and hydroxyzine on preoperative anxiety in pediatric patients undergoing adenotonsillectomy.

The primary outcomes:

1. Ease of parenteral separation.
2. The compliance to anesthesia induction in pediatric patients.

The secondary outcomes:

1. Assessment of postoperative pain.
2. Time to first analgesic request.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Effect of Drug Anxiety

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Melatonin Hydroxyzine Preoperative Anxiety Pediatric Adenotonsillectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Three study groups
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Melatonin

Preoperative oral melatonin 0.1mg/ kg in 10ml apple juice one hour before induction of anesthesia

Group Type ACTIVE_COMPARATOR

Melatonin 3 MG

Intervention Type DRUG

0.1 mg/ kg melatonin in 10 ml apple juice 1 hour before induction of anesthesia

Hydroxyzine

Preoperative oral hydroxyzine 1mg/ kg in 10ml apple juice one hour before induction of anesthesia

Group Type ACTIVE_COMPARATOR

Hydroxyzine Pill

Intervention Type DRUG

1 mg/ kg hydroxyzine in 10 ml apple juice 1 hour before induction of anesthesia

placebo

10ml apple juice one hour before induction of anesthesia

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

10 ml apple juice 1 hour before induction of anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Melatonin 3 MG

0.1 mg/ kg melatonin in 10 ml apple juice 1 hour before induction of anesthesia

Intervention Type DRUG

Hydroxyzine Pill

1 mg/ kg hydroxyzine in 10 ml apple juice 1 hour before induction of anesthesia

Intervention Type DRUG

Placebo

10 ml apple juice 1 hour before induction of anesthesia

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Melatonin Atarax 10mg

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. ASA: class l
2. Sex: male and female
3. Age: from 3 to 10 years old
4. Children scheduled for adenotonsillectomy

Exclusion Criteria

1. All children with a history of chronic illness, or developmental delay were excluded from the study
2. History of an autoimmune disease
3. Concurrent use of immunosuppressive treatment
4. Sleep disturbances, speech or communication problems
5. allergic to hydroxyzine, cetirizine, or other derivatives of piperazine, aminophylline, and ethylenediamine.
6. hydroxyzine is contraindicated in patients with acute porphyria

\-
Minimum Eligible Age

3 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sarah Mohamed Aly Omar Mousa

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Omar

Role: STUDY_DIRECTOR

Minia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sarah Omar

Al Minyā, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sarah Omar, M.D.

Role: CONTACT

Phone: +20100537617

Email: [email protected]

Hanafy

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sarah Omar

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

505/2022

Identifier Type: -

Identifier Source: org_study_id